بر اساس عنوان

1
Neuromuscular implications in left ventricular hypertrabeculation/noncompaction
2
Neuromuscular mechanisms and anthropometric modifications in the initial stages of independent gait
3
Neuromuscular Mechanisms of Primary Peristalsis
4
Neuromuscular neutral zones response to cyclic lumbar flexion
5
Neuromuscular neutral zones response to static lumbar flexion: Muscular stability compensator
6
Neuromuscular neutral zones sensitivity to lumbar displacement rate
7
Neuromuscular objectives of the human masticatory apparatus during static biting
8
Neuromuscular Problems in the Patients With COVID-19: A Review Study
9
Neuromuscular recovery in ACL reconstruction with Bone-Tendon-Patellar-Bone and Semitendinosus-Gracilis autograft
10
Neuromuscular Retraining versus BTX-A Injection in Subjects with Chronic Facial Nerve Palsy, A Clinical Trial
11
Neuromuscular symptoms and dysfunction in subclinical hypothyroid patients: beneficial effect of L-T4 replacement therapy
12
Neuromuscular variables affecting the magnitude of force loss after eccentric exercise
13
Neuromuscular versus behavioural influences on reaching performance in young and elderly women
14
Neuromyelitis optica — Devicʹs syndrome, update
15
Neuromyelitis Optica and Nucleotide Variations of Aquaporin-4 Gene
16
Neuromyelitis optica in a patient with an early onset demyelinating episode: Clinical and autoantibody findings
17
Neuromyelitis optica in a pregnant woman with systemic lupus erythematous: A case report
18
Neuromyelitis Optica in Children: A Rare Entity
19
Neuromyelitis optica spectrum disease characteristics in Isfahan, Iran: A cross‑sectional study
20
Neuromyelitis optica: what it is and what it might be
21
Neuromyotonia
22
Neuromyotonia, myocloni, sensory neuropathy and cerebellar symptoms in a patient with antibodies to neuronal nucleoproteins (anti-Hu-antibodies)
23
Neuromythology of Einstein’s brain
24
Neuron Cell Type-specific SNAP-25 Expression Driven by Multiple Regulatory Elements in the Nematode Caenorhabditis elegans
25
Neuron death due to unfolded protein response in gangliosidosis
26
Neuron death in ALS may be due to effects of neighbours
27
Neuron firing in driven nonlinear integrate-and-fire models
28
Neuron loss after coronary artery bypass detected by SPECT estimation of benzodiazepine receptors
29
Neuron loss in key cholinergic and aminergic nuclei in Alzheimer disease: a meta-analysis Review Article
30
Neuron Mathematical Model Representation of Neural Tensor Network for RDF Knowledge Base Completion
31
Neuron Numbers and Volume of the Amygdala in Subjects Diagnosed with Bipolar Disorder or Schizophrenia
32
Neuron source energy on resonance absorption
33
Neuronal activation and plasticity in Schistosoma mansoni infected mice
34
Neuronal activation in response to isoproterenol (Iso) in 6-day-old rat pups
35
Neuronal activity in the basal ganglia and thalamus in patients with dystonia
36
Neuronal and glial cell types revealed by NADPH-diaphorase histochemistry in the retina of a teleost fish, the grass goby (Zosterisessor ophiocephaluSy Perciformes, Gobiidae)
37
Neuronal and glial changes in the brain resulting from explosive blast in an experimental model
38
Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain
39
Neuronal and microglial cathepsins in aging and age-related diseases
40
Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: Developmental culling and cancer
41
Neuronal Approach and the Use of KIK-NET Network to Generate Response Spectrum on the Surface
42
Neuronal assemblies: necessity, signature and detectability
43
Neuronal autoantibodies in focal epilepsy with or without mesial temporal sclerosis
44
Neuronal BC1 RNA: Microtubule-dependent Dendritic Delivery
45
Neuronal CDK7 in hippocampus is related to aging and Alzheimer disease
46
Neuronal Cell Death in the Ischemic Spinal Cord: The Effect of Methylprednisolone
47
Neuronal cell death, nerve growth factor and neurotrophic models: 50 years on
48
Neuronal cell protective and antioxidant effects of phenolics obtained from Zanthoxylum piperitum leaf using in vitro model system
49
Neuronal Cell Reconstruction with Umbilical Cord Blood Cells in the Brain Hypoxia-Ischemia
50
Neuronal ceroid lipofuscinosis in a 31-year-old woman presenting as biventricular heart failure with restrictive features
51
Neuronal ceroid-lipofuscinosis: late infantile form or juvenile form?
52
Neuronal Changes in Normal Human Aging and Alzheimerʹs Disease
53
Neuronal circuitries involved in thermoregulation
54
Neuronal codes: reading them and learning how their structure influences network organization
55
Neuronal computers Original Research Article
56
Neuronal connections of the paratrigeminal nucleus: a topographic analysis of neurons projecting to bulbar, pontine and thalamic nuclei related to cardiovascular, respiratory and sensory functions
57
Neuronal contact guidance in magnetically aligned fibrin gels: effect of variation in gel mechano-structural properties
58
Neuronal Control of Metabolism through Nutrient-Dependent Modulation of Tracheal Branching
59
Neuronal correlates of “free will” are associated with regional specialization in the human intrinsic/default network
60
Neuronal Correlates of Colour-Graphemic Synaesthesia: Afmri Study
61
Neuronal correlates of context-related behavior
62
Neuronal Correlates of Obsessions in the Caudate Nucleus
63
Neuronal damage after hypothermic circulatory arrest and retrograde cerebral perfusion in the pig
64
Neuronal damage of the dorsal hippocampus induced by long-term right common carotid artery occlusion in rats
65
Neuronal death in the central nervous system during development
66
Neuronal degeneration and a decrease in laminin-like immunoreactivity is associated with elevated tissue-type plasminogen activator in the rat hippocampus after kainic acid injection
67
Neuronal differentiation modifies the effect of ethanol exposure on voltage-dependent calcium channels in NG 108-15 cells
68
Neuronal differentiation of induced pluripotent stem cells in hybrid polyester scaffolds with heparinized surface
69
Neuronal differentiation of mouse amnion membrane derived stem cells in response to neonatal brain medium
70
Neuronal Differentiation of Mouse Embryonic Stem Cells: Lineage Selection and Forced Differentiation Paradigms
71
Neuronal Differentiation of Rat Hair Follicle Stem Cells: the Involvement of the Neuroprotective Factor Seladin-1 (DHCR24)
72
Neuronal DNA damage correlates with overexpression of interleukin-1β converting enzyme in APPV717F mice
73
Neuronal effects of auditory distraction on visual attention
74
Neuronal Environment: the Brain Homeostasis in Health and Disease: W. Waltz, Humana Press, ISBN 0-89603-882-3, $145.00
75
Neuronal event detection in fMRI time series using iterative deconvolution techniques
76
Neuronal evolution: analysis of regulatory genes in a first-evolved nervous system, the hydra nervous system
77
Neuronal expression of Raf protooncogene in the brain stem of adult guinea pig
78
Neuronal feedback between brain and inner ear for growth of otoliths in fish Original Research Article
79
Neuronal firing activity in the dorsal hippocampus during the auditory discrimination oddball task in awake rats: relation to event-related potential generation
80
Neuronal function in chronic spinal cord injury: Divergence between locomotor and flexion- and H-reflex activity
81
Neuronal injury and death following focal mild brain injury: The role of network excitability and seizure
82
Neuronal Innervation, Intracellular Signal Transduction and Intercellular Coupling: a Model for Syncytial Tissue Responses in the Steady State
83
Neuronal Inputs from the Hypothalamus and Brain Stem to the Medial Preoptic Area of the Ram: Neurochemical Correlates and Comparison to the Ewe
84
Neuronal instability: implications for Rettʹs syndrome
85
Neuronal insulin signal transduction mechanisms in diabetes phenotypes
86
Neuronal intranuclear inclusion disease: neuropathologic study of a case
87
Neuronal kinase stimulation leads to aberrant tau phosphorylation and neurotoxicity
88
Neuronal kinase stimulation leads to aberrant tau phosphorylation and neurotoxicity
89
Neuronal lipofuscinosis
90
Neuronal loss and β-amyloid removal in the amygdala of people with Down syndromesmall star, filled
91
Neuronal loss in the colon of constipated Parkinsonʹs disease patients mimics that in the brain
92
Neuronal MAP2 mRNA: Species-dependent Differential Dendritic Targeting Competence
93
Neuronal maturation and N-acetyl-l-aspartic acid development in human fetal and child brains
94
Neuronal mechanisms mediating drug-induced cognition enhancement: cognitive activity as a necessary intervening variable
95
Neuronal Microtubule-associated Proteins: Insights into Their Structures and Functions
96
Neuronal migrational disorders in children with epilepsy: MRI, interictal SPECT and EEG comparisons
97
Neuronal nicotinic acetylcholine receptor binding affinities of boron-containing nicotine analogues
98
Neuronal nicotinic receptors and epilepsy, from genes to possible therapeutic compounds
99
Neuronal nicotinic receptors and ligands
100
Neuronal nitric oxide synthase (NNOS) catalyzes one-electron reduction of 2,4,6-trinitrotoluene, resulting in decreased nitric oxide production and increased nNOS gene expression: implication for oxidative stress
101
Neuronal nitric oxide synthase activity is increased during granulomatous inflammation in the colon and caecum of pigs infected with Schistosoma japonicum
102
Neuronal Nitric Oxide Synthase Expression in the Anterior Vaginal Wall of Patients with Stress Urinary Incontinence
103
Neuronal nitric oxide synthase gene transfer decreases [Ca2+]i in cardiac sympathetic neurons
104
Neuronal Nitric Oxide Synthase is Refractory to Mechanism-Based Inactivation in GH3Pituitary Cells
105
Neuronal Nitric Oxide Synthase–Membrane Phospholipid Interactions
106
Neuronal NO synthase (NOS1) is a major candidate gene for asthma
107
Neuronal nuclear antigen (NeuN): a marker of neuronal maturation in the early human fetal nervous system
108
Neuronal organization and cell interactions of the cat stellate ganglion
109
Neuronal pathology in the hippocampal area of patients with bipolar disorder: a study with proton magnetic resonance spectroscopic imaging
110
Neuronal pathway from the liver modulates energy expenditure and systemic insulin sensitivity
111
Neuronal Phenomena Associated with Vigilance and Consciousness: From Cellular Mechanisms to Electroencephalographic Patterns,
112
Neuronal plasticity and survival in mood disorders
113
Neuronal polo-like kinase in Alzheimer disease indicates cell cycle changes
114
Neuronal porosome – The secretory portal at the nerve terminal: Its structure–function, composition, and reconstitution
115
Neuronal projections from ventral tegmental area to forebrain structures in rat studied by manganese-enhanced magnetic resonance imaging
116
Neuronal representations of cognitive state: reward or attention?
117
Neuronal stem cells: a tale of promise and caution
118
Neuronal Store-Operated Calcium Entry Pathway as a Novel Therapeutic Target for Huntingtonʹs Disease Treatment Original Research Article
119
Neuronal subpopulations and genetic background in tauopathies: a catch 22 story?
120
Neuronal subserving of behavior before and after chronic ethanol treatment
121
Neuronal substrates of sensory gating within the human brain
122
Neuronal substrates participating in attentional set-shifting of rules for visually guided motor selection: a functional magnetic resonance imaging investigation
123
Neuronal Subtype Specification within a Lineage by Opposing Temporal Feed-Forward Loops
124
Neuronal susceptibility to damage: comparison of the retinas of young, old and old/caloric restricted rats before and after transient ischemia
125
Neuronal synchrony detection on single-electron neural networks
126
Neuronal target genes of the neuron-restrictive silencer factor in neurospheres derived from fetuses with Downʹs syndrome: a gene expression study
127
Neuronal toxicity of biopolymer-template synthesized ZnO nanoparticles
128
Neuronal, mesenchymal and hematopoietic cell derived from CD34− lin− cell from adult bone marrow
129
Neuronally-expressed necdin gene: an imprinted candidate gene in Prader-Willi syndrome
130
Neuronavigated repetitive transcranial magnetic stimulation in patients with tinnitus: a short case series
131
Neuronavigation assisted endoscopic sinus surgery
132
Neuronavigation for Intraoperative Localization of Cerebral Aneurysms
133
Neuronavigation for transcranial magnetic stimulation (TMS): Where we are and where we are going
134
Neuron-based VLSI architecture for real-time camera distortion correction
135
Neuron-controlled robots
136
Neuron-MOS Parallel Search Hardware for Real-Time Signal Processing
137
Neuronorm is a potent and water soluble neurokinin A receptor antagonist
138
Neurons and neuronal systems involved in the pathophysiologies of Rett syndrome
139
Neurons bearing neurofibrillary tangles are responsible for selected synaptic deficits in Alzheimerʹs disease
140
Neurons don’t represent
141
Neurons in amygdala mediate ear pinna vasoconstriction elicited by unconditioned salient stimuli in conscious rabbits
142
Neurons lose inhibitions in epilepsy
143
Neurons regenerate in absence of reactive astrocytes
144
Neurons, Cooperativity and the Role of Noise in Brain
145
Neurons, glia, and plasticity in normal brain aging
146
Neurons, viscose fluids, freshwater polyp hydra-and self-organizing information systems
147
Neuron-specific enolase and tau protein as neurobiochemical markers of neuronal damage are related to early clinical course and long-term outcome in acute ischemic stroke
148
Neuron-specific enolase antibodies in patients with sudden acquired retinal degeneration syndrome
149
Neuron-specific enolase antibodies in patients with sudden acquired retinal degeneration syndrome
150
Neuron-Specific enolase as a marker for acute ischemic stroke: A systematic review
151
Neuron-specific enolase as a marker of the severity and outcome of hypoxic ischemic encephalopathy
152
Neuron-specific enolase in cerebrospinal fluid as a neurochemical marker for brain damage in acute lymphoblastic leukemia
153
Neuron-specific enolase increases in plasma during and immediately after extracorporeal circulation
154
Neuron-specific enolase levels in the cerebrospinal fluid of neurologically healthy children
155
Neuron-specific enolase, nucleotides, nucleosides, purine bases, oxypurines and uric acid concentrations in cerebrospinal fluid of children with meningitis
156
Neuron-specific susceptibility to apolipoprotein E4
157
Neuron-synapse IC chip-set for large-scale chaotic neural networks
158
Neuron-tumor Interaction in Prostate Cancer: Implications and Future Perspective
159
Neuron-type polypyrrole device prepared by electrochemical polymerization method and its properties
160
Neuro-oncology for non-oncologists
161
Neuro-oncology for Nurses; Edited by Douglas Guerrero, Whur Publishers Ltd, £24.50
162
Neuro-oncology: diagnosis in the spotlight
163
Neuro-oncology: new insights and advances in treatment
164
Neuro-oncology: oligodendroglioma and molecular markers
165
Neuro-oncology: setting new standards of management
166
Neuro-oncology: the growing role of chemotherapy in glioma
167
Neuro-Ophthalmologic and Electroretinographic Finding in Pantothenate Kinae-Aociated Neurodegeneration (formerly Hallervorden-patz yndrome)
168
Neuro-Ophthalmologic Preentation of Hemicrania Continua
169
Neuro-ophthalmologic Recovery Following Endoscopic Endonasal Resection of Pituitary Macro-adenomas with Apoplexy
170
Neuro-ophthalmology review manual, revied 5th edition: Lanning B. Kline and Frank J. Bajanda. lack Incorporated: Thorofare, NJ; 2004.288 page$44.95 UDIBN 1-55642-672-0Media type: Review Manual
171
Neuro-Ophthalmology, The Requiite in Ophthalmology. Edited by Timothy J. Martin and Jame J. Corbett. t. Loui, Miouri, Moby Inc., 2000. Index, illutrated, 256 page. $89.00.
172
Neuro-ophthalmology: Neuronal Control of Eye Movements .A. Straube and U. Büttner Editors Basel Karger (2007).
173
Neuro-ophthalmology—Diagnoi and Management. Liu GT, Volpe NJ, Baletta L. New York, W.B. aunder, 2001. 756 page, index, illutrated. About $135.00
174
Neuro-optimal operation of a variable air volume HVAC&R system
175
Neuro-Optometry, Neuro-Optometrist, and Neuro-Optometric Rehabilitative Implications
176
Neuro-otologic Manifestations of Multiple Sclerosis
177
Neuro-otological features of Benign Paroxysmal Vertigo and Benign Paroxysmal Positioning Vertigo in children: A follow-up study
178
Neuropathic agents and pain. New strategies
179
Neuropathic arthropathy of the shoulder associated with syringomyelia: a report of six cases
180
Neuropathic arthropathy of the shoulder associated with syringomyelia: a report of six cases
181
Neuropathic diabetic patients do not have reduced variability of plantar loading during gait
182
Neuropathic elbow arthropathy: A review of six cases
183
Neuropathic gait shows only trends towards increased variability of sagittal plane kinematics during treadmill locomotion
184
Neuropathic injury to the levator ani occurs in 1 in 4 primiparous women
185
Neuropathic manifestations in rheumatoid arthritis : A clinical and electrophysiological assessment in a small sample of Iraqi patients.
186
Neuropathic Orofacial Pain: Proposed Mechanisms, Diagnosis, and Treatment Considerations
187
Neuropathic Osteoarthropathy in a Patient with Congenital Insensitivity to Pain
188
Neuropathic pain
189
Neuropathic pain
190
NEUROPATHIC PAIN
191
Neuropathic pain in hereditary coproporphyria
192
Neuropathic pain in soft tissue complaints
193
Neuropathic pain research pinpoints new role for microglia
194
Neuropathic Pain Treatment Gives Avigen New Lease on Life and Neuromed Follows the Snail Trail
195
Neuropathic Pain Treatment Gives Avigen New Lease on Life and Neuromed Follows the Snail Trail
196
Neuropathic Pain: A Review of Interneuronal Disinhibition
197
Neuropathic pain: aetiology, symptoms, mechanisms, and management
198
Neuropathic symptoms and findings in women with Fabry disease
199
Neuropathie radio-induite du nerf optique après traitement pour cancer du nasopharynx. ہ propos de deux cas et revue de la littérature
200
Neuropathie radio-induite du nerf optique après traitement pour cancer du nasopharynx. ہ propos de deux cas et revue de la littérature
201
Neuropathies of the foot
202
Neuropathogenicity of Equine Herpesvirus 9 in Cattle
203
Neuropathologic study of long term cyanide administration to goats
204
Neuropathological alteration of aquaporin 1 immunoreactive enteric neurons in the streptozotocin-induced diabetic rats
205
Neuropathological analysis of the brainstem and cerebral cortex lesions on epileptogenesis in hereditary dentatorubral-pallidoluysian atrophy
206
Neuropathological assessment of artemether-treated severe malaria
207
Neuropathological Changes in Brain Cortex and Hippocampus in a Rat Model of Alzheimer’s Disease
208
NEUROPATHOLOGICAL CHANGES IN THE PDAPP TRANSGENIC MOUSE MODEL OF ALZHEIMER S DISEASE
209
Neuropathological characteristics and alteration of the dopamine D2 receptor in hypoxic-ischemic basal ganglia necrosis
210
Neuropathological Criteria for the Diagnosis of Alzheimer’s Disease
211
Neuropathological Criteria for the Diagnosis of Alzheimer’s Disease: Are We Really Ready Yet?
212
Neuropathological Diagnosis of Alzheimer’s Disease: A Perspective from Longitudinal Clinicopathological Studies
213
Neuropathological epidemiology of cerebral aging: a study of two genetic polymorphisms
214
Neuropathological findings in the cerebro-oculo-facio-skeletal (Pena-Shokeir II) syndrome
215
Neuropathological markers of impaired cognition in the entorhinal cortex
216
Neuropathological Staging of Alzheimer-Related Lesions: The Challenge of Establishing Relations to Age
217
Neuropathological studies of brain tissue in schizophrenia
218
Neuropathologies of the self: Clinical and anatomical features
219
Neuropathology and Genetics of Dementia, Edited by Tolnay M. and Probst A., Kluwer Academic/Plenum Publ., London, 2000.
220
Neuropathology in controls and demented subjects from the Baltimore longitudinal study of aging
221
Neuropathology of bipolar disorder
222
Neuropathology of chronic chagasic cardiopathy: A diagnostic reassessment
223
Neuropathology of developmental abnormalities
224
Neuropathology of early-infantile epileptic encephalopathy with suppression-bursts; comparison with those of early myoclonic encephalopathy and West syndrome
225
Neuropathology of mitral valve prolapse in man and cardiopulmonary bypass (CPB) surgery in adolescent Yorkshire pigs
226
Neuropathology of prion diseases
227
Neuropathology of the limbic system and brainstem in West syndrome
228
Neuropathology of tuberous sclerosis
229
Neuropathology of variant Creutzfeldt-Jakob disease
230
Neuropathy complicating diffuse infiltrative lymphocytosis
231
Neuropathy in type 1 diabetic renal transplanted patients
232
Neuropathy of the suprascapular nerve and massive rotator cuff tears: a prospective electromyographic study
233
Neuropathy, axonal Na+/K+ pump function and activity-dependent excitability changes in end-stage kidney disease
234
Neuropathy-induced osteopenia in rats is not due to a reduction in weight born on the affected limb
235
Neuro-PD Controller of Structural System to Mitigate Earthquake Vibrations
236
Neuropeptide deficits in schizophrenia vs. Alzheimerʹs disease cerebral cortex
237
Neuropeptide deficits in schizophrenia vs. Alzheimerʹs disease cerebral cortex
238
Neuropeptide Delivery to Synapses by Long-Range Vesicle Circulation and Sporadic Capture
239
Neuropeptide enzyme hydrolysis in human saliva
240
Neuropeptide expression following ligation of the ferret lingual nerve
241
Neuropeptide expression in the ferret trigeminal ganglion following ligation of the inferior alveolar nerve
242
Neuropeptide FF attenuates RANKL-induced differentiation of RAW264.7 cells into osteoclast-like cells
243
Neuropeptide may shift rheumatoid arthritis into remission
244
Neuropeptide specificity of prostaglandin E2-induced activation of splenic and renal sympathetic nerves in the rat
245
Neuropeptide transmitters released from VAN into the NTS play an important role in regulating food intake
246
Neuropeptide Y (NPY) and NPY Y1 receptor in periodontal health and disease
247
Neuropeptide Y (NPY) revealed biological activity in leucocytes of Salmo salar
248
Neuropeptide Y (NPY): Genetic Variation in the Human Promoter Alters Glucocorticoid Signaling, Yielding Increased NPY Secretion and Stress Responses
249
Neuropeptide Y administered into cerebral ventricles stimulates sucrose ingestion in the near-term ovine fetus
250
Neuropeptide Y administration into the amygdala does not affect ethanol consumption
251
Neuropeptide Y and nitrite levels in preeclamptic and normotensive gravid women
252
Neuropeptide Y expression, localization and cellular transducing effects in HUVEC
253
Neuropeptide Y Gene Promoter -399T/C Polymorphism Increases Risk of Ischemic Stroke
254
Neuropeptide Y immunohistochemistry and ultrastructure of developing chromaffin tissue in the cloudy dogfish, Scyliorhinus torazame (Chondrichthyes, Elasmobranchii)
255
Neuropeptide Y in male and female brains of flinders sensitive line, a rat model of depression. Effects of electroconvulsive stimuli
256
Neuropeptide Y in neural crest-derived tumors: Effect on growth and vascularization
257
Neuropeptide Y in the rostral ventrolateral medulla blocks somatosympathetic reflexes in anesthetized rats
258
Neuropeptide Y Inhibits in Vivo Specific Antibody Production in Rats
259
Neuropeptide Y modulation of sympathetic activity in myocardial infarction
260
Neuropeptide Y mRNA expression in interneurons in rat spinal cord
261
Neuropeptide Y rapidly enhances [Ca2+]i transients and Ca2+ sparks in adult rat ventricular myocytes through Y1 receptor and PLC activation
262
Neuropeptide Y receptors; antisecretory control of intestinal epithelial function
263
Neuropeptide Y reduces acetylcholine release and vagal bradycardia via a Y2 receptor-mediated, protein kinase C-dependent pathway
264
Neuropeptide Y restores appetite and alters concentrations of GH after central administration to endotoxic sheep
265
Neuropeptide Y signal peptide Pro7 substitution protects against coronary artery atherosclerosis: The Helsinki Sudden Death Study
266
Neuropeptide Y suppresses ethanol drinking in ethanol-abstinent, but not non–ethanol-abstinent, Wistar rats
267
Neuropeptide Y Y1 receptor functional responsiveness is enhanced during cardiomyocyte hypertrophy
268
Neuropeptide Y, α-melanocyte–stimulating hormone, and monoamines in food intake regulation
269
Neuropeptide Y1 Receptor NPY1R: Discovery of Naturally Occurring Human Genetic Variants Governing Gene Expression In Cella as Well as Pleiotropic Effects on Autonomic Activity and Blood Pressure In Vivo
270
Neuropeptide Y1 receptor NPY1R: discovery of naturally occurring human genetic variants governing gene expression in cella as well as pleiotropic effects on autonomic activity and blood pressure in vivo.
271
Neuropeptide Y-Y1 receptor modulates nitric oxide level during stroke in the rat
272
NEUROPEPTIDES (SP an‎d CGRP) AUGMENT IL-1 BETA PRODUCTION IN HSV-INFECTED MACROPHAGES
273
Neuropeptides and endothelial injury in cutaneous vasculitis
274
Neuropeptides and obesity
275
Neuropeptides: opportunities for drug discovery
276
Neuropeptide-Y, cortisol, and subjective distress in humans exposed to acute stress: replication and extension of previous report
277
Neuropharmacological activity of the aqueous leaf extract of Croton zambesicus (euphorbiaceae) in some laboratory animals
278
Neuropharmacological approach against MPTP (1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine)-induced mouse model of Parkinson’s disease
279
Neuropharmacological Effect of the Rhizome of Drynaria quercifolia in Mice
280
Neuropharmacological Effects of Chassalia curviflora (Rubiaceae) Leaves in Swiss Albino Mice Model
281
Neuro-pharmacological effects of Crinum zeylanicum in mice
282
Neuropharmacological effects of methanolic extracts of Rubus fruticosus L.
283
Neuropharmacological effects of Nigella sativa
284
Neuropharmacological effects of Ocimum basilicum and its constituents
285
Neuropharmacological effects of standardized aqueous stem bark extract of Parkia biglobossa in Wistar rats
286
Neuropharmacological key to cortical plasticity found
287
Neuropharmacological properties of farnesol in Murine model
288
Neuropharmacological studies of ethanolic extract of Vaccinium corymbosum on Alzheimer’s type dementia and catatonia in Swiss albino mice
289
Neuropharmacological studies with spect in neuropsychiatric disorders
290
Neuropharmacology of depression in aging and age-related diseases
291
Neuropharmacology of endogenous, synthetic andphytocannabinoids for pain management
292
Neuropharmacology of timing and time perception
293
Neuropharmacology of timing and time perception: [Cognitive Brain Research 3 (1996) 227–242]
294
Neurophenomenology and the study of self-consciousness
295
Neurophil reactive chlorinating species target tissue plasmalogens: Production of 2-chlorohexadecal
296
Neurophysical theory of coherence and correlations of electroencephalographic and electrocorticographic signals
297
Neurophysiologic and intellectual evaluation of beta-thalassemia patients
298
Neurophysiologic assessment of mucopolysaccharidosis III
299
Neurophysiologic consequences of neonatal ethanol exposure in the rat
300
Neurophysiologic correlates of deficient phonological representations and object naming in prematurely born children
301
Neurophysiologic correlates of psychiatric disorders and potential applications in epilepsy
302
Neurophysiologic detector—a selective and sensitive tool in high-performance liquid chromatography
303
Neurophysiologic findings in early acute inflammatory demyelinating polyradiculoneuropathy
304
Neurophysiological and behavioral concomitants of mild brain injury in collegiate athletes
305
Neurophysiological and behavioral indices of time pressure effects on visuomotor task performance
306
Neurophysiological and behavioural evidence for an olfactory function for the dorsal organ and a gustatory one for the terminal organ in Drosophila melanogaster larvae
307
Neurophysiological and functional MRI evidence of reorganization of cortical motor areas in cerebral arteriovenous malformation
308
Neurophysiological and mitochondrial abnormalities in MuSK antibody seropositive myasthenia gravis compared to other immunological subtypes
309
Neurophysiological assessment of the sedative and analgesic effects of a constant rate infusion of dexmedetomidine in the dog
310
Neurophysiological assessment of trigeminal nerve reflexes in disorders of central and peripheral nervous system
311
Neurophysiological bases underlying the organization of intentional actions and the understanding of others’ intention
312
Neurophysiological changes associated with psychiatric symptoms in HIV-infected individuals without AIDS
313
Neurophysiological Changes Associated with Selective Neuronal Damage in Hippocampus following Transient Forebrain Ischemia
314
Neurophysiological characteristics of photophobia in migraine
315
Neurophysiological correlate of clinical signs in Parkinsonʹs disease
316
Neurophysiological Correlates of Affiliative Behaviour between Humans and Dogs
317
Neurophysiological correlates of subjective significance
318
Neurophysiological correlates of the recognition of facial expressions of emotion as revealed by magnetoencephalography
319
Neurophysiological effects of recurrent laryngeal and thoracic vagus nerves on mediating the neurogenic inflammation of the trachea, bronchi, and esophagus of rats
320
Neurophysiological evaluation of symptomatically unaffected muscles in post polio syndrome (PPS)
321
Neurophysiological evaluation of vigilance in epileptic patients on monotherapy with lamotrigine
322
Neurophysiological evidence for categorical perception of color
323
Neurophysiological evidence of cognitive inhibition anomalies in persons with major depressive disorder
324
Neurophysiological follow-up of motor cortical output in stroke patients
325
Neurophysiological index is a marker of functional impairment in amyotrophic lateral sclerosis
326
Neurophysiological indices of attention to speech in children with specific language impairment
327
Neurophysiological indices of strategy development and skill acquisition
328
Neurophysiological investigation of a chronic sensory ataxia
329
Neurophysiological marker of inhibition distinguishes language groups on a non-linguistic executive function test
330
Neurophysiological markers in familial amyloid polyneuropathy patients: Early changes
331
Neurophysiological markers of contextual processing: The relationship between P3b and Gamma synchrony and their modulation by arousal, performance and individual differences
332
Neurophysiological markers of early language acquisition: from syllables to sentences
333
Neurophysiological mechanisms underlying motor evoked potentials in anesthetized humans.: Part 1. Recovery time of corticospinal tract direct waves elicited by pairs of transcranial electrical stimuli
334
Neurophysiological mechanisms underlying motor evoked potentials in anesthetized humans.: Part 2. Relationship between epidurally and muscle recorded MEPs in man
335
Neurophysiological Methods in Occupational and Environmental Health: Methodology and Recent Findings
336
Neurophysiological monitoring in vascular surgery
337
Neurophysiological Responses to Traumatic Reminders in the Acute Aftermath of Serious Motor Vehicle Collisions Using [15O]-H2O Positron Emission Tomography
338
Neurophysiological self-control: Modulation in all things
339
Neurophysiological signals of working memory in normal aging
340
Neurophysiological signs of cocaine dependence: Increased electroencephalogram beta during withdrawal
341
Neurophysiological study in Pelizaeus-Merzbacher disease
342
Neurophysiological study of corticomotor pathways in restless legs syndrome
343
Neurophysiological study of facial chorea in patients with Huntingtonʹs disease
344
Neurophysiological study of secondary synchronous occipito-frontopolar spikes in childhood
345
Neurophysiological study on possible protective and therapeutic effects of Sidr (Zizyphus spina-christi L.) leaf extract in male albino rats treated with pentylenetetrazol
346
Neurophysiological study on sensorimotor control mechanism in superior colliculus of echolocating bat
347
Neurophysiological techniques in patients who are secondarily non-responsive to Botulinum toxin
348
Neurophysiologist reprimanded by UK General Medical Council
349
Neurophysiology and neuroanatomy of reflexive and volitional saccades as revealed by lesion studies with neurological patients and transcranial magnetic stimulation (TMS)
350
Neurophysiology and neuroanatomy of reflexive and volitional saccades: Evidence from studies of humans
351
Neurophysiology and neuroanatomy of reflexive and voluntary saccades in non-human primates
352
Neurophysiology and neuroanatomy of smooth pursuit in humans
353
Neurophysiology and neuroanatomy of smooth pursuit: Lesion studies
354
Neurophysiology for Detection of High Risk for Psychosis
355
Neurophysiology in the intensive care unit: Size (of surals) matters
356
Neurophysiology of Parkinsonʹs disease: from basic research to clinical correlates
357
Neurophysiology of Rett syndrome
358
Neurophysiology of Social Conduct and Impact of Adverse Exposures
359
Neurophysiology of spasms
360
Neurophysiology of swallowing
361
Neurophysiology of the neurogenic lower urinary tract disorders
362
Neurophysiology of Touretteʹs syndrome: pathophysiological considerations
363
Neurophysiology of unimanual motor control and mirror movements
364
Neurophysiology reference tome
365
Neuro-PID tracking control of a discharge air temperature system
366
Neuropil Alteration of the Habenula Nucleus in the Experimental Model of Schizophrenia Induced by Ketamine
367
Neuropilin-1 Expreion by Endothelial Cell and Retinal Pigment Epithelial Cell in Choroidal Neovacular Membrane
368
Neuropilins and semaphorins — from angiogenesis to autoimmunity
369
Neuroplasticity and schizophrenia
370
Neuroplasticity as a function of second language learning: Anatomical changes in the human brain
371
Neuroplasticity changes during space flight Original Research Article
372
Neuroplasticity Changes of Rat Brain by Musical Stimuli during Fetal Period
373
Neuroplasticity of face primary motor cortex control of orofacial movements
374
Neuroplasticity of face sensorimotor cortex and implications for control of orofacial movements
375
Neuroplasticity: Evidence from aphasia
376
Neuropolitics gone mad
377
Neuroprophylaxis with aminophylline and magnesium sulfate?
378
Neuroprostheses for leg function after spinal-cord injury
379
Neuroprotection after cardiac arrest
380
Neuroprotection After Traumatic Brain Injury: Is There any Hope?
381
Neuroprotection against ischemic brain injury conferred by a novel nitrate ester
382
Neuroprotection and anxiety like behavior reduction of Allium hirtifolium and Astragalus hamosus in the AB-injected rat
383
NEURO-PROTECTION AND NEURO-THERAPY EFFECTS OF Acalypha indica Linn. WATER EXTRACT EX VIVO ON Musculus gastrocnemius Frog
384
Neuroprotection and pharmacotherapy for motor symptoms in Parkinsonʹs disease
385
Neuroprotection and the role of neuroglobin
386
Neuroprotection by KATP channels
387
Neuroprotection by the Metabolic Antioxidant α-Lipoic Acid
388
Neuroprotection disappointment yet aGAIN
389
Neuroprotection Effect of Quercetin on TNF- Levels and Gene Expression of Caspase 3 in MPTP-Induced Male NMRI Mice
390
Neuroprotection failure in stroke
391
Neuroprotection for acute ischaemic stroke: hope reignited
392
Neuroprotection for Parkinsonʹs disease: a call for clinically riven experimental design
393
Neuroprotection in acute ischaemic stroke: a tale of for whom the bell tolls?
394
Neuroprotection in Cardiac Surgery
395
Neuroprotection in epilepsy: The Holy Grail of antiepileptogenic therapy
396
Neuroprotection in Glaucoma
397
Neuroprotection in Glaucoma
398
Neuroprotection in multiple sclerosis
399
Neuroprotection in Parkinsonʹs Disease
400
Neuroprotection in Parkinsonʹs disease: and now for something completely different?
401
Neuroprotection of a sesamin derivative, 1, 2-bis [(3-methoxy- phenyl) methyl] ethane-1, 2-dicaroxylic acid (MMEDA) against ischemic and hypoxic neuronal injury
402
Neuroprotective (+) 3S, 4S cannabinoids with modified 5′-side chain
403
Neuroprotective activities of acai berries (Euterpe sp.): A review
404
Neuroprotective activity of omega-3 fatty acids against epilepsy-induced hippocampal damage: Quantification with immunohistochemical for calcium–binding proteins
405
Neuroprotective adaptations in hibernation: therapeutic implications for ischemia-reperfusion, traumatic brain injury and neurodegenerative diseases
406
Neuroprotective Agents for Management of Parkinson’s disease
407
Neuroprotective agents: Cannabinoids
408
Neuroprotective and Antiamnesic Effects of Mitragyna inermis Willd (Rubiaceae) on Scopolamine-Induced Memory Impairment in Mice
409
Neuroprotective and anti-inflammatory effects of flavonoids isolated from Rhus verniciflua in neuronal HT22 and microglial BV2 cell lines
410
Neuroprotective and Anti-inflammatory Role of Atorvastatin and Its Interaction with Nitric Oxide (NO) in Chronic Constriction Injury-induced Neuropathic Pain
411
Neuroprotective and anti-neuroinflammatory activity of frankincense in bile duct ligation-induced hepatic encephalopathy
412
Neuroprotective and memory enhancing effects of Zataria multiflora in lipopolysaccharide-treated rats
413
Neuroprotective and neurorestorative signal transduction mechanisms in brain aging: modification by genes, diet and behavior
414
Neuroprotective and Nootropic Activity of Carica Papaya Seeds on Diabetes induced Cognitive Decline in Rats
415
Neuroprotective and Nootropic Drug Noopept Rescues α-Synuclein Amyloid Cytotoxicity
416
Neuroprotective antioxidant effect of sex steroid hormones in traumatic brain injury
417
Neuroprotective biflavonoids of Chamaecyparis obtusa leaves against glutamate-induced oxidative stress in HT22 hippocampal cells
418
Neuroprotective Consequences of Postconditioning on Embolic Model of Cerebral Ischemia in Rat
419
Neuroprotective Effect of Matricaria chamomilla Extract on Motor Dysfunction Induced by Transient Global Cerebral Ischemia and Reperfusion in Rat
420
Neuroprotective Effect of 4T1 and Sertoli Cells CoTransplantation in Animal Model of Brain Ischemia
421
Neuroprotective effect of Acorus calamus Linn. extract on a rat model of chronic constriction injury of median nerve-induced peripheral neuropathy
422
Neuroprotective effect of ACTH (4-9) in degeneration of hippocampal nerve cells caused by dexamethasone: morphological, immunocytochemical and ultrastructural studies
423
Neuroprotective effect of agmatine in rats with transient cerebral ischemia using MR imaging and histopathologic evaluation
424
Neuroprotective effect of alkyl hydroxytyrosyl ethers in rat brain slices subjected to a hypoxia-reoxygenation model
425
Neuroprotective effect of berberine chloride on cognitive impairment and hippocampal damage in experimental model of vascular dementia
426
Neuroprotective effect of blackberry (Rubus sp.) polyphenols is potentiated after simulated gastrointestinal digestion
427
Neuroprotective Effect of Celastrus Paniculatus Seed Extract on Epilepsy and Epilepsy-associated Cognitive Deficits
428
Neuroprotective Effect of Coenzyme Q10 in Chronic Constriction Injury-Induced Neuropathic Pain in Rat
429
Neuroprotective effect of Coenzyme Q10 in hippocampal injury in Balb/c mouse
430
Neuroprotective effect of Coenzyme Q10 on ischemic hemisphere in aged mice with mutations in the amyloid precursor protein
431
Neuroprotective Effect of DAHP via Antiapoptosis in Cerebral Ischemia
432
Neuroprotective effect of Decalepis hamiltonii roots against ethanol-induced oxidative stress
433
Neuroprotective effect of dimethyl fumarate in stroke: The role of nuclear factor erythroid 2-related factor 2
434
Neuroprotective Effect of Erythropoietin in Postoperation Cervical Spinal Cord Injury: Case Report and Review
435
Neuroprotective effect of ethanolic leaf extract of Commiphora caudata (Wight Arn) against lipopolysaccharide-induced neurotoxicity in Wistar rats
436
Neuroprotective Effect of Exogenous Melatonin on Dopaminergic Neurons of the Substantia Nigra in Ovariectomized Rats
437
Neuroprotective effect of geraniol and curcumin in an acrylamide model of neurotoxicity in Drosophila melanogaster: Relevance to neuropathy
438
Neuroprotective effect of ginger on anti-oxidant enzymes in streptozotocin-induced diabetic rats
439
Neuroprotective effect of hexasulfobutylated C60 on rats subjected to focal cerebral ischemia
440
Neuroprotective effect of Launaea taraxacifolia against neuroinflammation, memory loss and neurobehavioral deficit in a rat model of hypertension: biochemical and immunohistochemical approaches
441
Neuroprotective effect of L-deprenyl on the expression level of the Mst1 gene and inhibition of apoptosis in rat-model spinal cord injury
442
Neuroprotective effect of melatonin in a rat model ofstreptozotocin-induced diabetic neuropathy: Light andelectron microscopic study
443
Neuroprotective Effect of Melatonin in the Hippocampus of Rat’s Brain in Normal Aging Model
444
Neuroprotective Effect of Melatonin on Brain Damage Induced by Acute Global Cerebral Ischemia in Cats
445
Neuroprotective effect of memantine on serum S100-B levels after on-pump coronary artery bypass graft surgery: A randomized clinical trial
446
Neuroprotective effect of methanolic extract of Sargassum wightii on rotenone-induced parkinsonism-like symptoms in Wistar albino rats
447
Neuroprotective Effect of Paroxetine on Memory Deficit Induced by Cerebral Ischemia after Transient Bilateral Occlusion of Common Carotid Arteries in Rat
448
Neuroprotective effect of p-coumaric acid in rat model of embolic cerebral ischemia
449
Neuroprotective Effect of Pentoxifylline on 3,4-Methylenedioxymethamphetamine-Induced Apoptosis in CA1 Cells of Wistar Rat Hippocampus
450
Neuroprotective Effect of Quercetin Encapsulated Liposomes: A Novel Therapeutic Strategy against Alzheimerʹs Disease
451
Neuroprotective Effect of Quercetin in a Model of Parkinson’s Disease in Rat: A histochemical Analysis
452
Neuroprotective effect of selective antegrade cerebral perfusion during prolonged deep hypothermic circulatory arrest: Cerebral metabolism evidence in a pig model
453
Neuroprotective effect of thymoquinone in acrylamide-induced neurotoxicity in Wistar rats
454
Neuroprotective Effect of Thymoquinone, the Nigella Sativa Bioactive Compound, in 6-Hydroxydopamine-Induced Hemi-Parkinsonian Rat Model
455
Neuroprotective Effect of Total and Sequential Extract of Scrophularia striata Boiss. in Rat Cerebellar Granule Neurons Following Glutamate- Induced Neurotoxicity: An In-vitro Study
456
NEUROPROTECTIVE EFFECT OF VITAMIN C AGAINST PTZ INDUCED APOPTOTIC NEURODEGENERATION IN ADULT RAT BRAIN
457
Neuroprotective effect of water lily (Nymphaea pubescens Willd) seed ethanolic extract against trimethyltin-induced cognitive impairment and neurodegeneration in mice
458
Neuroprotective Effect of Zataria Multiflora Essential Oil on Rats With Alzheimer Disease: A Mechanistic Study
459
Neuroprotective Effects of 1,8-Cineole on Apoptosis Inhibition and Bcl-2/Caspase-3 mRNA Expression in the Hippocampus of Epileptic Pilocarpine Model Rats
460
Neuroprotective Effects of Acetyl-l-Carnitine After Stroke in Rats, , ,
461
Neuroprotective effects of alpha-lipoic acid on radiation-induced brainstem injury in rats
462
Neuroprotective effects of atomoxetine against traumatic spinal cord injury in rats
463
Neuroprotective Effects of Berberine Hydrochloride on Methamphetamine-induced Cognitive Dysfunction: Immunohistochemical and Behavioral Studies in Rats
464
Neuroprotective Effects of Bone Marrow Mesenchymal Stem Cells on Bilateral Common Carotid Arteries Occlusion Model of Cerebral Ischemia in Rat
465
Neuroprotective effects of caffeine against beta-amyliod neurotoxicity: The involvement of glycogen synthase kinase-3β protein
466
Neuroprotective Effects of Carnosic Acid in an Experimental Model of Alzheimer’s disease in Rats
467
Neuroprotective effects of carvacrol against Alzheimer’s disease and other neurodegenerative diseases: A review
468
Neuroprotective effects of celastrol on sciatic nerve transection model in male Wistar rats
469
Neuroprotective Effects of Chrysin Mediated by Estrogenic Receptors Following Cerebral Ischemia and Reperfusion in Male Rats
470
Neuroprotective effects of cobalt ferrite nanoparticles coated with sumac on damaged sciatic nerve recovery
471
Neuroprotective effects of cognitive enrichment
472
Neuroprotective Effects of Combined Treatment with Minocycline and Olfactory Ensheathing Cells Transplantation against Inflammation and Oxidative Stress after Spinal Cord Injury
473
Neuroprotective effects of Coriandrum sativum and its constituent, linalool: A review
474
Neuroprotective effects of crocin on the histopathological alterations following brain ischemia-reperfusion injury in rat
475
Neuroprotective effects of curculigoside against NMDA-induced neuronal excitoxicity in vitro
476
Neuroprotective Effects of Curcumin Against Transient Global Ischemia are Dose and Area Dependent
477
Neuroprotective Effects of Curcumin on the Proliferation and Viability of Neural Stem Cells against H2O2
478
Neuroprotective effects of cystamine in aged parkinsonian mice
479
Neuroprotective Effects of Ellagic Acid in a Rat Model of Parkinsonʹs Disease
480
Neuroprotective Effects of Epigallocatechin-3-Gallate in an Experimental Model of Alzheimer’s Disease in Rat: A Histological Study
481
Neuroprotective effects of Equisetum telmateia in rat
482
Neuroprotective effects of Eriobotrya japonica against β-amyloid-induced oxidative stress and memory impairment
483
Neuroprotective Effects of Erythropoietin in Acute Ischemic Stroke
484
Neuroprotective Effects of Exercise on Brain Edema and Neurological Movement Disorders Following the Cerebral Ischemia and Reperfusion in Rats
485
Neuroprotective Effects of Fe3O4 Nanoparticles Coated with Omega-3 as a Novel Drug for Recovery of Sciatic Nerve Injury in Rats
486
Neuroprotective effects of flavones on hydrogen peroxide-induced apoptosis in SH-SY5Y neuroblostoma cells
487
Neuroprotective effects of gallic acid in a rat model of traumatic brain injury: behavioral, electrophysiological, and molecular studies
488
Neuroprotective Effects of Herbal Extract (Rosa canina, Tanacetum vulgare and Urtica dioica) on Rat Model of Sporadic Alzheimer’s Disease
489
Neuroprotective effects of intense training and thyme honey on hippocampal cognitive pathways in diabetic rats
490
Neuroprotective Effects of Isoquercetin: An In Vitro and In Vivo Study
491
Neuroprotective effects of kobophenol A against the withdrawal of tropic support, nitrosative stress, and mitochondrial damage in SH-SY5Y neuroblastoma cells
492
Neuroprotective Effects of Medicinal Plants and Their Constituents on Different Induced Neurotoxicity Methods: A Review
493
Neuroprotective Effects of Memantine in the Retina of Glaucomatous Rats: An Electron Microscopic Study
494
Neuroprotective effects of naturally occurring biflavonoids
495
Neuroprotective effects of neolignans isolated from Magnoliae Cortex against glutamate-induced apoptotic stimuli in HT22 cells
496
Neuroprotective Effects of Normobaric Hyperoxia and Transplantation of Encapsulated Choroid Plexus Epithelial Cells on The Focal Brain Ischemia
497
Neuroprotective effects of oral gallic acid against oxidative stress induced by 6-hydroxydopamine in rats
498
Neuroprotective effects of Pinus eldarica in a mouse model of pentylenetetrazole-induced seizures
499
Neuroprotective Effects of Pramipexole in Parkinson s Disease Induced by Rotenone in Mice
500
Neuroprotective Effects of Progesterone on Damage Elicited by Acute Global Cerebral Ischemia in Neurons of the Caudate Nucleus
501
Neuroprotective effects of propolis and caffeic acid phenethyl ester (CAPE) on the radiation-injured brain tissue (Neuroprotective effects of propolis and CAPE)
502
Neuroprotective effects of resveratrol on embryonic dorsal root ganglion neurons with neurotoxicity induced by ethanol
503
Neuroprotective effects of rosemary extract on white matter of prefrontal cortex in old rats
504
Neuroprotective effects of Salvia aristata Aucher ex Benth. on hydrogen peroxide induced apoptosis in SH-SY5Y neuroblastoma cells
505
Neuroprotective effects of Schisandrin B against transient focal cerebral ischemia in Sprague–Dawley rats
506
Neuroprotective effects of selenium and ginkgo biloba extract (EGb761) against ischemia and reperfusion injury in rat brain
507
Neuroprotective Effects of Semaglutide in Endotoxemia Mouse Model
508
Neuroprotective effects of silymarin on sodium fluoride-induced oxidative stress
509
Neuroprotective effects of statins may not be related to total and low-density lipoprotein cholesterol lowering
510
Neuroprotective effects of Tacca chantrieri Andre against lipopolysaccharide-induced cognitive impairment and neuroinflammation
511
Neuroprotective effects of Tiliacora triandra leaf extract in a mice model of cerebral ischemia reperfusion
512
Neuroprotective Effects of Transplanted Mesenchymal Stromal Cells-derived Human Umbilical Cord Blood Neural Progenitor Cells in EAE
513
Neuroprotective Effects of Vitamin D on Patients With Traumatic Brain Injury: A Clinical Trial
514
Neuroprotective Effects of Vitexin and Cajanus cajan Extract Against Pb-induced Neurotoxicity in Wistar Rats
515
Neuroprotective effects of voluntary wheel running and eriobotrya japonica flower extract on Parkinsonian rats
516
Neuroprotective effects of walnut (Juglans regia L.) in nervous system disorders: A comprehensive review
517
Neuroprotective effects of Wharton’s jelly-derived mesenchymal stem cells on motor deficits due to Parkinson’s disease
518
Neuroprotective effects of Withania coagulans root extract on CA1 hippocampus following cerebral ischemia in rats
519
Neuroprotective effects of xanthone derivative of Garcinia mangostana against lead-induced acetylcholinesterase dysfunction and cognitive impairment
520
Neuroprotective effects of Z-ajoene, an organosulfur compound derived from oil-macerated garlic, in the gerbil hippocampal CA1 region after transient forebrain ischemia
521
Neuroprotective effects of α-lipoic acid and its positively charged amide analogue
522
Neuroprotective gene profile in the brain of magnesium-deficient mice
523
Neuroprotective mechanism of bromocriptine
524
Neuroprotective or neurotoxic activity of 1-methyl-1,2,3,4-tetrahydroisoquinoline and related compounds
525
Neuroprotective Plants; What, How, an‎d Why? A Narrative Review
526
Neuroprotective potential of some terebinth coffee brands and the unprocessed fruits of Pistacia terebinthus L. and their fatty and essential oil analyses
527
Neuroprotective Potential of Trans-Anethole Following Crush Injury of the Sciatic Nerve in Rats
528
Neuroprotective Properties of Melissa Officinalis L. Extract Against Ecstasy-Induced Neurotoxicity
529
Neuroprotective properties of Melissa officinalisafter hypoxic-ischemic injury both in vitro and in vivo
530
Neuroprotective Properties of Photobiomodulation in Retinal Regeneration in Rats: Perspectives From Interaction Levels
531
Neuroprotective properties of Spanish red wine and its isolated polyphenols on astrocytes
532
Neuroprotective role of curcumin on the hippocampus against the structural and serological alterations of streptozotocin-induced diabetes in Sprague Dawely rats
533
Neuroprotective role of vitamin D3 in colchicine-induced Alzheimer’s disease in rats
534
Neuroprotective roles of flavonoid “hispidulin” in the central nervous system: A review
535
Neuroprotective Strategies in the Perioperative Period: A Systematic Review
536
Neuroprotective therapy for acute ischaemic stroke: down, but not out
537
Neuroprotective Treatment With FK506 Reduces Hippocampal Damage and Prevents Learning and Memory Deficits After Transient Global Ischemia in Rat
538
Neuroprotective, antimicrobial, antioxidant, chemotherapeutic, and antidiabetic properties of Salvia Reuterana: A mini review
539
Neuroproteomics comes of age
540
Neuropsychiaric perspective and recommendations
541
Neuropsychiatric and neuropsychological manifestations of central pontine myelinolysis
542
Neuropsychiatric and Psychosocial Issues of Patients With Hepatitis C Infection: A Selective Literature Review
543
Neuropsychiatric aspects in Munchausenʹs syndrome
544
Neuropsychiatric aspects of epilepsy in children
545
Neuropsychiatric aspects of patients with hypothalamic hamartomas
546
Neuropsychiatric changes after liver transplantation
547
Neuropsychiatric Complications Following Liver Transplantation
548
NEUROPSYCHIATRIC COMPLICATIONS IN LIVER TRANSPLANT PATIENTS IN A TERTIARY HOSPITAL IN SINGAPORE
549
Neuropsychiatric Complications of COVID-19: What is to be Expected
550
Neuropsychiatric effects of medications for allergic diseases
551
Neuropsychiatric features of systemic lupus erythematosus
552
Neuropsychiatric Function and Dehydroepiandrosterone Sulfate in Elderly Women: A Prospective Study
553
Neuropsychiatric Illness: A Case for Impaired Neuroplasticity and Possible Quantum Processing Derailment in Microtubules
554
Neuropsychiatric implications of basal ganglia dysfunction
555
Neuropsychiatric Lupus
556
Neuropsychiatric lupus erythematosus: A 10-year prospective study on the value of diagnostic tests,
557
Neuropsychiatric Manifestations in a Patientwith Panhypopituitarism
558
Neuropsychiatric Manifestations of COVID-19 in Hospitalized Pediatrics: A Multicenter Cross-sectional Study
559
Neuropsychiatric Manifestations of Partial Agenesis ofthe Corpus Callosum: A Case Report and Literature Review
560
Neuropsychiatric perspectives on nodding syndrome in northern Uganda: a case series study and a review of the literature
561
Neuropsychiatric profiles of patients with juvenile myoclonic epilepsy treated with valproate or topiramate
562
Neuropsychiatric reaction induced by abacavir
563
Neuropsychiatric reactions with mefloquine chemoprophylaxis
564
Neuropsychiatric sequelae in a case of St. Louis Encephalitis
565
Neuropsychiatric Symptoms As The First Manifestation of Juvenile Systemic Lupus Erythematosus: A Complicated Case With Klinefelterʹʹs Syndrome
566
Neuropsychiatric Syndromes and Occupational Exposure to Zinc Phosphide in Egypt
567
Neuropsychiatric systemic lupus erythematosus: Correlation of brain MR imaging, CT, and SPECT
568
Neuropsychiatric toxicity of Ifosfamide in patients admitted for chemotherapy
569
Neuropsychiatry and Behavioral Neuroscience
570
Neuropsychiatry in old age : by C. Stefanis and H. Hippius, 1996, Hogrefe & Huber Publishers, Seattle, USA, 171 pages, US$ 32, ISBN 0-88937-137-7
571
Neuropsychiatry, second edition.R.B. Schiffer, S.M. Roa and B.S. Fogel, Editors, Lippincott Williams & Wilkins, Philadelphia (2003) $169, 1312 pages.
572
Neuropsychiatry—a discipline for the future
573
Neuropsychiatryʹs offspring
574
Neuropsychiatry—The mind embrained?
575
Neuro-Psychoanalysis May Enliven the Mindbrain Sciences
576
Neuropsychologic and Functional Recovery From Severe Carbon Monoxide Poisoning Without Hyperbaric Oxygen Therapy, , ,
577
Neuropsychologic Changes After Coronary Artery Bypass Grafting: Use of Reliable Change Indices
578
Neuropsychologic functioning among the nonpsychotic relatives of schizophrenic patients: the effect of genetic loading
579
Neuropsychologic Impairment in Patients with Nonepileptic Seizures
580
Neuropsychologic impairments in bipolar and unipolar mood disorders on the CANTAB neurocognitive battery
581
Neuropsychologic Theory and Findings in Attention-Deficit/Hyperactivity Disorder: The State of the Field and Salient Challenges for the Coming Decade
582
Neuropsychological abnormalities in cirrhosis include learning impairment
583
Neuropsychological and anatomical correlates of E4 in Alzheimerʹs disease
584
Neuropsychological and behavioral disorders as presentation symptoms in two brothers with early-infantile Niemann-Pick type C
585
Neuropsychological and cognitive psychophysiological substrates of impulsive aggression
586
Neuropsychological and Diagnostic Differences Between Recidivistically Violent Not Criminally Responsible and Mentally Ill Prisoners
587
Neuropsychological and emotional changes during simulated microgravity: effects of triiodothyronine, alendronate, and testosterone
588
Neuropsychological and Emotional Functioning in Patients with Cushing's Syndrome
589
Neuropsychological and mood effects of ketamine in electroconvulsive therapy: A randomised controlled trial
590
Neuropsychological and neurological correlates in an elderly rural population
591
Neuropsychological and neurophysiological deficits in extremely high velocity traumatic brain injury: A case report
592
Neuropsychological and Neuropsychiatric Deficits Following Traumatic Brain Injury: Common Patterns and Neuropathological Mechanisms
593
Neuropsychological and psychiatric changes after deep brain stimulation for Parkinsonʹs disease: a randomised, multicentre study
594
Neuropsychological and psychiatric impact of add-on titration of pregabalin versus levetiracetam: A comparative short-term study
595
Neuropsychological and QEEG assessment of adult ADHD
596
Neuropsychological aspects of chronic relapsing pancreatitis: A longitudinal case study
597
Neuropsychological aspects of epilepsy surgery
598
Neuropsychological aspects of Tourette syndrome: A review
599
Neuropsychological aspects of type of epilepsy and etiological factors in adults
600
Neuropsychological assessment and volumetric magnetic resonance imaging of the corpus callosum in dementia
601
Neuropsychological Assessment In Epilepsy Surgery – Preliminary Experience In A Rural Tertiary Care Hospital In North East Malaysia
602
Neuropsychological assessment in patients evaluated for hyperthermia for metastatic nonsmall lung carcinoma (FDA phase 1 and phase 2)
603
Neuropsychological assessment of a rare systemic vascular disorder: a case study of Rendu—Osler—Weber syndrome
604
Neuropsychological Assessment of Organic Solvent Effects in South Africa: Test Selection, Adaptation, Scoring, and Validation Issues
605
Neuropsychological assessment of persons with physical disability, visual impairment or blindness, and hearing impairment or deafness
606
Neuropsychological assessment of relatively intact individuals: Psychometric lessons from an HIV+ sample
607
Neuropsychological assessment of the blind and visually impaired
608
Neuropsychological assessments before and aftertreatment in patients with anorexia nervosa and bulimianervosa
609
Neuropsychological change following gamma knife surgery in patients with left temporal lobe epilepsy: a review of three cases
610
Neuropsychological changes and treatment compliance in older adults with sleep apnea
611
Neuropsychological Changes in Complex Regional Pain Syndrome (CRPS)
612
Neuropsychological characterization of hepatic encephalopathy
613
Neuropsychological complaint base rates in personal injury, revisited
614
Neuropsychological consequences of bilateral deep brain stimulation of the subthalamic nucleus for the treatment of Parkinsonʹs disease: A 1-year longitudinal follow-up
615
Neuropsychological consequences of HIV in children: A review of current literature
616
Neuropsychological consequences of right thalamic haemorrhage: Case study and review
617
Neuropsychological consequences of sequential concussions in a female college basketball player
618
Neuropsychological correlates between working memory and executive functioning
619
Neuropsychological correlates of adjunct therapy with a nutritional/vitamin supplement in a medical patient sample
620
Neuropsychological Correlates of Community Function among Major Depressive Disorder Outpatients without Comorbidity in Hong Kong: An Exploratory Cross‑Sectional Study
621
Neuropsychological correlates of dominance, warmth, and extraversion in neurodegenerative disease
622
Neuropsychological correlates of Gulf War syndrome
623
Neuropsychological correlates of homocysteine levels in euthymic bipolar patients
624
Neuropsychological Correlates of Methylphenidate Treatment in Adult ADHD With and Without Depression
625
Neuropsychological correlates of opioid dependence and withdrawal
626
Neuropsychological correlates of psychopathic traits in a non-incarcerated sample
627
Neuropsychological correlates of psychotic features in major depressive disorders: a review and meta-analysis
628
Neuropsychological correlates of self-reported impulsive aggression in a college sample
629
Neuropsychological correlates of violence and aggression: A review of the clinical literature
630
Neuropsychological decline following herpes zoster without encephalitis: A case study
631
Neuropsychological Decomposing Stroop Interference Into Different Cognitive Monitoring: An Exploratory Factor Analysis
632
Neuropsychological deficit profiles in senile dementia of the Alzheimerʹs type
633
Neuropsychological deficits among patients with late-onset minor and major depression
634
Neuropsychological deficits associated with chronic hepatitis C among male veterans
635
Neuropsychological deficits in bipolar depression persist after successful antidepressant treatment
636
Neuropsychological deficits in marijuana smokers
637
Neuropsychological deficits in probands from multiply-affected schizophrenic families
638
Neuropsychological deficits of patients with chronic or acute cerebellar lesions
639
Neuropsychological developmental change in a case with Noonan syndrome: longitudinal assessment
640
Neuropsychological Disorders in Patients with Brain Tumor
641
Neuropsychological dissociations between motion and form perception suggest functional organization in extrastriate cortical regions in the human brain
642
Neuropsychological double dissociation between linguistic levels: Clinical linguistic evidence from Iranian aphasic patients
643
Neuropsychological dysfunction after minimally invasive direct coronary artery bypass grafting
644
Neuropsychological Dysfunction in Children with Borderline Personality Disorder Features: A Preliminary Investigation
645
Neuropsychological dysfunction in patients suffering from end-stage chronic obstructive pulmonary disease
646
Neuropsychological dysfunction in patients with end-stage pulmonary disease: lung transplant evaluation
647
Neuropsychological dysfunction in patients with end-stage pulmonary disease: Lung transplant evaluation
648
Neuropsychological dysfunction in schizotypal personality disorder: A profile analysis
649
Neuropsychological Effects of Chronic Exposure to Environmental Dioxins and Furans
650
Neuropsychological effects of epilepsy and antiepileptic drugs
651
Neuropsychological effects of exposure to sheep dip
652
Neuropsychological effects of long-term exposure to organophosphates in sheep dip
653
Neuropsychological effects of seizures
654
Neuropsychological effects of stress on social phobia with and without comorbid depression
655
Neuropsychological evaluation in rehabilitation planning and evaluation of functional skills
656
Neuropsychological evaluation in the diagnosis and management of sports-related concussion
657
Neuropsychological Evaluation of Older Children : By Ralph M. Reitan and Deborah Wolfson, South Tucson, AZ: Neuropsychology Press, 1992. + 814 pp
658
Neuropsychological evidence for dimensional schizotypy: Implications for creativity and psychopathology
659
Neuropsychological exploration of alleged mold neurotoxicity
660
Neuropsychological explorations of memory and cognition: Essay in honor of Nelson butters :Eidted by Laird S. Cermak, N ew York: Plenum Press, 1994.
661
Neuropsychological features of diffuse Lewy body disease
662
Neuropsychological Features of Multiple Sclerosis: Impact and Rehabilitation
663
Neuropsychological findings in adult attention deficit disorder
664
Neuropsychological findings in young-adult stroke patients
665
Neuropsychological follow-up of high risk infants at school age: Wechsler Verbal-Performance discrepancies
666
Neuropsychological function and cerebral glucose utilization in isolated memory impairment and Alzheimers disease
667
Neuropsychological function and psychosocial status of alcohol rehabilitation program residents
668
Neuropsychological function in adults with attention-deficit hyperactivity disorder
669
Neuropsychological function in female victims of intimate partner violence with and without posttraumatic stress disorder
670
Neuropsychological function in unmedicated recurrent brief depression
671
Neuropsychological functioning following bilateral subthalamic nucleus stimulation in Parkinson’s disease
672
Neuropsychological functioning in a subclinical obsessive-compulsive sample
673
Neuropsychological Functioning in Adolescent Children of Mothers with a History of Bipolar or Major Depressive Disorders
674
Neuropsychological functioning in adult insulin-dependent diabetes mellitus (IDDM) patients
675
Neuropsychological Functioning in Bipolar Disorder and Schizophrenia
676
Neuropsychological functioning in chronic lyme disease: The role of mental effort
677
Neuropsychological Functioning in Danish Gulf War Veterans
678
Neuropsychological functioning in depressed adolescent girls
679
Neuropsychological functioning in kleptomania
680
Neuropsychological functioning in major depression and responsiveness to selective serotonin reuptake inhibitors antidepressants
681
Neuropsychological Functioning in Migraine Headache, Nonheadache Chronic Pain, and Mild Traumatic Brain Injury Patients
682
Neuropsychological Functioning in Obsessive-Compulsive Washers: Drug-Naive Without Depressive Symptoms
683
Neuropsychological functioning in people with ADHD across the lifespan
684
Neuropsychological functioning in sons of active alcoholic, recovering alcoholic, and social drinking fathers
685
Neuropsychological functioning in trichotillomania
686
Neuropsychological functioning in two brothers with X-linked adrenoleukodystrophy: A longitudinal case study of phenotypic variation and bone marrow transplant outcome
687
Neuropsychological Functioning in Youth with Bipolar Disorder
688
Neuropsychological functioning of children and adolescents with conduct disorder and aggressive-assaultive features
689
Neuropsychological functioning of dementia patients with psychosis
690
Neuropsychological Functioning of Inmates Referred for Psychiatric Treatment
691
Neuropsychological Functioning: Comparison of Mothers at High- and Low-Risk for Child Physical Abuse
692
Neuropsychological functions and the BASC
693
Neuropsychological functions in anxiety disorders in population-based samples: evidence of episodic memory dysfunction
694
Neuropsychological impairment after hemorrhagic stroke in basal ganglia
695
Neuropsychological impairment associated with compulsive hoarding
696
Neuropsychological impairment in fibromyalgia: Relation to depression, fatigue, and pain
697
Neuropsychological information in the Wechsler adult intelligence scale—revised
698
Neuropsychological Interventions: Clinical Practice and Research: By Paul J. Eslinger. New York: The Guilford Press, 2002, 359 pages
699
Neuropsychological Manifestation in Ebola: A Concern
700
Neuropsychological measures probably facilitate heritability research of ADHD
701
Neuropsychological outcome and quantitative neuroimaging in mild head injury,
702
Neuropsychological Outcome and the Extent of Resection in the Unilateral Temporal Lobectomy
703
Neuropsychological outcome following focal cortical removal for intractable epilepsy in children
704
Neuropsychological Outcome following Resuscitation after Out-of-Hospital Cardiac Arrest: A One-Year Follow-Up
705
Neuropsychological Outcome in Children after Frontal Lobe Epilepsy Surgery
706
Neuropsychological Outcome of Head Injury Using a Short Battery
707
NEUROPSYCHOLOGICAL OUTCOMES OF NOCTURNAL ASTHMA
708
Neuropsychological outcomes of pediatric burn patients who sustained hypoxic episodes
709
Neuropsychological parameters of pediatric migraineurs and tensioneurs
710
Neuropsychological performance deficits in adults with attention deficit/hyperactivity disorder
711
Neuropsychological performance in a sample of 13–25 year olds with a history of non-psychotic major depressive disorder
712
Neuropsychological performance in adult attention-deficit hyperactivity disorder: Meta-analysis of empirical data
713
Neuropsychological performance in bipolar I, bipolar II and unipolar depression patients: A longitudinal, naturalistic study
714
Neuropsychological Performance in Children and Adolescents with Obsessive-Compulsive Disorder and Influence of Clinical Variables
715
Neuropsychological Performance in First-Episode Adolescents with Schizophrenia: A Comparison with First-Episode Adults and Adolescent Control Subjects
716
Neuropsychological performance in gravesʹ hyperthyroidism: Evidence for executive dysfunction
717
Neuropsychological Performance in Gulf War Era Veterans: Motivational Factors and Effort
718
Neuropsychological Performance in Gulf War Era Veterans: Neuropsychological Symptom Reporting
719
Neuropsychological Performance in Gulf War Era Veterans: Traumatic Stress Symptomatology and Exposure to Chemical–Biological Warfare Agents
720
Neuropsychological performance in men and women at risk for hypertension
721
Neuropsychological performance in normal pregnancy and preeclampsia
722
Neuropsychological performance in pediatric bipolar disorder
723
Neuropsychological performance in schizotypal personality disorder: evidence regarding diagnostic specificity
724
Neuropsychological performance of a clinical sample of extremely obese individuals
725
Neuropsychological Performance of Adults Evidencing Attention-Deficit Hyperactivity Disorder
726
Neuropsychological performance of monozygotic twins discordant for bipolar disorder
727
Neuropsychological Performance Over Time in People at High Risk of Developing Schizophrenia and Controls
728
Neuropsychological performance predicts clinical recovery in bipolar patients
729
Neuropsychological predictors of adaptive living and work behaviors
730
Neuropsychological predictors of emotional prosody: Implications for hemispheric asymmetry
731
Neuropsychological Profile at Three Months Post Injury in Patients with Traumatic Brain Injury
732
Neuropsychological profile in patients with obsessive-compulsive disorder over a period of 4-month treatment
733
Neuropsychological Profile of a Large Kindred with Familial Alzheimerʹs Disease Caused by the E280A Single Presenilin-1 Mutation
734
Neuropsychological profile of patients with juvenile myoclonic epilepsy: A controlled study of 50 patients
735
Neuropsychological profile of prodromal Alzheimerʹs disease (Prd-AD) and their radiological correlates
736
Neuropsychological Profiles Associated with Subcortical White Matter Alterations and Parkinsonʹs Disease:: Implications for the Diagnosis of Dementia
737
Neuropsychological profiles of children diagnosed as specific language impaired with and without hyperlexia
738
Neuropsychological recovery from childhood moyamoya disease
739
Neuropsychological Sequelae in a Series of Patients with End-Stage Cystic Fibrosis: Lung Transplant Evaluation
740
Neuropsychological sequelae in subacute home chlordane poisoning: Ten case studies
741
Neuropsychological Similarities and Differences Among Huntington’s Disease, Multiple Sclerosis, and Cortical Dementia
742
Neuropsychological Studies of Late Onset and Subthreshold Diagnoses of Adult Attention-Deficit/Hyperactivity Disorder
743
Neuropsychological study of ciguatera fish poisoning: A longitudinal case-control study
744
Neuropsychological Test Development and Normative Data on Hispanics
745
Neuropsychological test performance and prediction of functional capacities among Spanish-speaking and English-speaking patients with dementia
746
Neuropsychological test performance in a cognitively intact sample of older Japanese American adults
747
Neuropsychological Test Performance in Illiterate Subjects
748
Neuropsychological test performance of children with ADHD relative to test norms and parent behavioral ratings
749
Neuropsychological Test Performances of Young Depressed Outpatient Women: An Examination of Executive Functions
750
Neuropsychological testing defines the neurobehavioral significance of neuroimaging-identified abnormalities
751
Neuropsychological testing of adults: further considerations for neurologists
752
Neuropsychological testing of high school athletes: Preliminary norms and test–retest indices
753
Neuropsychological tests and SPECT in dementing disorders
754
Neuropsychological tests predict independent activities of daily living in patients with dementia
755
Neuropsychological toxicology: Identification and assessment of human neurotoxic syndromes : Second Edition, by David E. Hartman. New York: Plenum Press, 1995. 429 pp, $59.50 hardcover
756
Neuropsychological, Neuroanatomical, and Neurophysiological Consequences of CNS Chemotherapy for Acute Lymphoblastic Leukemia
757
Neuropsychological, olfactory, and hygiene deficits in men with negative symptom schizophrenia
758
Neuropsychologistsʹ Practice Patterns in Assessing Premorbid Intelligence
759
Neuropsychologists’ abilities to determine the predictive value of diagnostic tests
760
Neuropsychology and linguistic aphasiology: Evidence in favor of case studies
761
Neuropsychology is nothing without control: A potential fallacy hidden in clinical studies
762
Neuropsychology of Alzheimerʹs Disease
763
Neuropsychology of bipolar disorder: a review
764
Neuropsychology of BPI and BPII
765
Neuropsychology of BPI and BPII
766
Neuropsychology of BPI and BPII
767
Neuropsychology of developmental stuttering
768
Neuropsychology of dual diagnosis: Understanding the combined effects of schizophrenia and substance use disorders
769
Neuropsychology of obsessive-compulsive disorder: a review and treatment implications
770
Neuropsychology of timing and time perception
771
Neuropsychology, the Patientʹs Experience, and the Political Forces Within Our Field
772
Neuroptera in agricultural ecosystems
773
Neuropteran (Insecta) palaeodiversity with predictions for the Cretaceous fauna of the Wealden
774
Neuroradiologic MR applications with multiparametric color composite display
775
Neuroradiological assessment of brain structure and function and its implication in the pathogenesis of West syndrome
776
Neuroradiological findings in primary cerebral lymphomas of non-AIDS patients
777
Neuroradiology of spine degenerative diseases
778
Neuroreceptor subunit genes and the genetic susceptibility to gilles de la tourette syndrome
779
Neurorehabilitation, the Practical Method of Returning to Work after Stroke
780
Neurorehabilitation: no more constraint for large randomised trials
781
Neuroretinal function is normal in early dementia of the Alzheimer type
782
Neurosarcoidosis
783
Neurosarcoidosis presenting as a large suprasellar mass: Magnetic resonance imaging findings
784
Neurosarcoidosis presenting with simple partial seizures and solitary enhancing mass: case reports and review of the literature
785
Neurosarcoidosis: a clinical dilemma
786
Neurosarcoidosis: a treatable cause of vestibular dysfunction
787
Neurosarcoidosis: Findings in MRI
788
Neuroscience and computing algorithms
789
Neuroscience and the soul: Competing explanations for the human experience
790
Neuroscience approach in Stem cell therapy among patients with Spinal Cord Injury
791
Neuroscience as an Insightful Decision Support Tool for Sustainable Development
792
Neuroscience meets dance/movement therapy: Mirror neurons, the therapeutic process and empathy
793
Neuroscience output of China: A MEDLINE-based bibliometric study
794
Neuroscience research on the addictions: A prospectus for future ethical and policy analysis
795
Neuroscience, neuroimaging and the law
796
Neuroscience, quantum indeterminism and the Cartesian soul
797
Neuroscience: Where is it heading?: Some reflections on the future of brain research at the end of the second millenium
798
Neuroscience-Informed Psychoeducation for Recovery: A Program to Promote Metacognition in People With Substance Use Disorders
799
Neurosciences Quiz: Subclinical rhythmic electrographic discharges of adults (SREDA): Case Presentation
800
Neurosciences, psychiatrie et psychopathologie : quelles évolutions pour la relation clinique ?
801
Neuroscientific challenges to free will and responsibility
802
Neuroscientists discover disgusting regions of the brain
803
Neuroscientists hear impassioned plea from Superman
804
Neuroscientists take a BOLD step forward
805
Neuro-Second Order Sliding Mode Control of a DFIG Supplied by a Two-Level NSVM Inverter for Wind Turbine System
806
Neurosensory changes of palatal mucousa following Le Fort I osteotomy
807
Neuro-short-term load forecast of the power system in Kuwait
808
Neuro-simulation analysis of pressure maintenance operations in gas condensate reservoirs
809
Neuro-simulation modeling of chemical flooding
810
Neurosolver: Neuromorphic general problem solver
811
Neurosphere-Free Transdifferentiation of Rat Bone Marrow Stromal Stem Cells Into Retinal Cells and Retinal Pigment Epithelium
812
Neurospora crassa CyPBP37: A Cytosolic Stress Protein that is able to Replace Yeast Thi4p Function in the Synthesis of Vitamin B1
813
Neurospora crassa FKBP22 Is a Novel ER Chaperone and Functionally Cooperates with BiP
814
Neurosteroid analogues. Part 13: Synthetic methods for the preparation of 2β-hydroxygonane derivatives as structural mimics of ent-3α-hydroxysteroid modulators of GABAA receptors
815
Neurosteroid analogues: synthesis of 6-aza-allopregnanolone
816
Neurosteroid analysis by gas chromatography–atmospheric pressure photoionization–tandem mass spectrometry Original Research Article
817
Neurosteroid dehydroepiandrosterone attenuates 6-hydroxydopamine-induced apoptosis in a cell model of Parkinson's disease
818
Neurosteroids in Rat Brain: Extraction, Isolation, and Analysis by Nanoscale Liquid Chromatography-Electrospray Mass Spectrometry
819
Neurosteroids: 7-aza-allopregnanolone—a poor substitute for allopregnanolone
820
Neurostimulation as a Putative Method for the Treatment of Drug-resistant Epilepsy in Patient and Animal Models of Epilepsy
821
Neurosurgeons report gains in treatment of vascular malformations
822
Neurosurgeons wake up to awake-brain surgery
823
Neurosurgery 7000 years ago in central Italy
824
Neurosurgery in a cold climate
825
Neurosurgery Practice During the COVID-19 Pandemic
826
Neurosurgical Approaches in Demyelinating Disorders; Where are We Now?
827
Neurosurgical Care of Nonpowder Firearm Injuries: A Narrative Review of the Literature
828
Neurosurgical Development in the East, Central and Southern African (ECSA) Region
829
Neurosurgical emergencies, volumes I and II : Christopher Loftus, MD, editor. American Association of Neurological Surgeons, 1994
830
Neurosurgical evacuation of intracranial hemorrhage after thrombolytic therapy for acute myocardial infarction: Experience from the GUSTO-I Trial, , , ,
831
NEUROSURGICAL IN-PATIENT PROFILE:A THREE-YEAR AUDIT IN A REGIONAL CENTRE
832
Neurosurgical management of pain: by Richard B. North and Robert M. Levy, Springer Verlag, New York, 1997, ISBN 0-387-94256-4
833
Neurosurgical Operating Room Nurse’s Roles and Responsibilities
834
Neurosurgical procedures for refractory OCD
835
Neurosurgical Procedures in Jehovah’s Witnesses: The Tema Experience
836
Neurosurgical treatment for Gilles de la Tourette syndrome: The Italian perspective
837
Neurosyphilis presenting as refractory status epilepticus
838
Neurosyphilis with Hydrocephalus: A Case Report
839
Neurotensin receptor binding abnormalities in the entorhinal cortex in schizophrenia and affective disorders
840
NeuroTheology and Its Convergence with NeuroQuantology
841
Neurotheology: The relationship between brain and religion.
842
Neurotic butterflies in my stomach: The role of anxiety, anxiety sensitivity and depression in functional gastrointestinal disorders
843
Neurotic disorders in the elderly : J. Lindesay (ed.) Oxford University Press, Oxford (1995). xiii + 250 pp. £39.50
844
Neuroticism and academic achievement: the Furneaux Factor as a measure of academic rigour
845
Neuroticism and affective priming: Evidence for a neuroticism-linked negative schema
846
Neuroticism and attachment insecurity as predictors of bereavement outcome
847
Neuroticism and extraversion as predictors of coping styles during early adolescence
848
Neuroticism and extraversion share genetic and environmental effects with negative and positive mood spillover in a nationally representative sample
849
Neuroticism and Fibromyalgia Syndrome: A Systematic Review and Meta-analysis
850
Neuroticism and introversion: A risky combination for disordered eating among a non-clinical sample of undergraduate women
851
Neuroticism and low educational level predict the risk of posttraumatic stress disorder in women after miscarriage or stillbirth
852
Neuroticism and mental health outcomes for long-term unemployed youth attending occupational skills training programs
853
Neuroticism and self-criticism associated with posttraumatic stress disorder in a nationally representative sample
854
Neuroticism and the facilitation of the automatic orienting of attention
855
Neuroticism as a mediator of treatment response to SSRIs in major depressive disorder
856
Neuroticism but not cardiovascular stress reactivity is associated with less longitudinal blood pressure increase
857
Neuroticism predicts normal variability in the number of circulating leucocytes
858
Neuroticism predicts resting frontal EEG asymmetry variability
859
Neuroticism prospectively predicts pain among adolescents: Results from a nationally representative sample
860
Neuroticism, alexithymia and medically unexplained symptoms
861
Neuroticism, alexithymia, negative affect, and positive affect as determinants of medically unexplained symptoms
862
Neuroticism, cognitive ability, and the metabolic syndrome: The Vietnam Experience Study
863
Neuroticism, daily hassles, and depressive symptoms: An examination of moderating and mediating effects
864
Neuroticism, depression, and depression proneness
865
Neuroticism, Life Events and Negative Thoughts in the Development of Depression in Adolescent Girls
866
Neuroticism, preattentive and attentional biases towards threat, and anxiety before and after a severe stressor: a prospective study
867
Neuroticism, psychiatric symptoms and life events
868
Neuroticism: a non-informative marker of vulnerability to psychopathology
869
Neuroticism: moderator or mediator in the relation between locus of control and depression?
870
Neurotics are dissatisfied with life, but not with services. The South Verona Outcome Project 7
871
Neurotolerability of Gadobenate Dimeglumine Evaluation of Brain Dopamine Concentration in Freely Moving Rats by Microdialysis
872
Neurotolerability of Gadobenate Dimeglumine in a Rat Model of Focal Brain Ischemia: EEG Evaluation
873
Neurotological findings in a patient with narrow internal auditory canal: a case report
874
Neurotoxic and hepatotoxic cyanotoxins removal by nanofiltration
875
Neurotoxic Disorders of Organophosphorus Compounds and Their Managements
876
Neurotoxic effect and metabolic responses induced by a mixture of six pesticides on the earthworm Aporrectodea caliginosa nocturna Original Research Article
877
Neurotoxic effect of lead on rats: Relationship to Apoptosis
878
Neurotoxic effect of linamarin in rats associated with cassava (Manihot esculenta Crantz) consumption
879
Neurotoxic Effects of 2,5-Hexanedione on Rapidly Growing Unmyelinated Peripheral Nerve Axons of a Rat Fetus: Dose–Effect Relationship
880
Neurotoxic effects of 25 mg/kg/bodyweight of artemether on the histology of the trapezoid nuclei and behavioural functions in adult male Wistar rats
881
Neurotoxic Effects of Fractionated Diesel Exhausts Following Microinjections in Rat Hippocampus and Striatum
882
Neurotoxic effects of gasoline and gasoline constituents : T. M. Burbacher. Environmental Health Perspectives Supplements, 101(Suppl. 6), 133–141
883
Neurotoxic Effects of Low Level Exposure to Manganese in Human Populations,
884
Neurotoxic Effects of Low-Level Methylmercury Contamination in the Amazonian Basin
885
Neurotoxic effects of neonatal triethyltin (TET) exposure are exacerbated with aging
886
Neurotoxic lesioning of oxytocin-sensing hindbrain neurons attenuates the satiety response to CCK-8
887
Neurotoxic marine poisoning
888
Neurotoxic Syndromes and Occupational Exposure to Solvents
889
Neurotoxicity and Behavioral Alterations Following Subchronic Administration of Aqueous Extract of Erythrophleum Ivorense Stem Bark in Mice
890
Neurotoxicity and Neuroprotective Effects of Polyimides (PI) and Polyphenylenevinylene (PPV) against Hydrogen Peroxide (H2O2)
891
Neurotoxicity and occupational exposure to PCBs
892
Neurotoxicity Associated with Occupational Exposure to Acetone, Methyl Ethyl Ketone, and Cyclohexanone,
893
Neurotoxicity from Airborne Chemicals Around a Superfund Site
894
Neurotoxicity from glutathione depletion is mediated by Cu-dependent p53 activation
895
Neurotoxicity of 1-bromopropane: Evidence from animal experiments and human studies
896
Neurotoxicity of 2-Bromopropane and 1-Bromopropane, Alternative Solvents for Chlorofluorocarbons,
897
Neurotoxicity of Aβ amyloid protein in vitro is not altered by calcium channel blockade
898
Neurotoxicity of Coscinium fenestratum stem, a medicinal plant used in traditional medicine
899
Neurotoxicity of Dextrorphan
900
Neurotoxicity of gadolinium contrast agents for magnetic resonance imaging in rats with osmotically disrupted blood-brain barrier
901
Neurotoxicity of intrathecal local anaesthetics and transient neurological symptoms
902
Neurotoxicity of Manganese Chloride in Neonatal and Adult CD Rats Following Subchronic (21-Day) High-Dose Oral Exposure
903
Neurotoxicity of nitroxyl: Insights into HNO and NO biochemical imbalance
904
Neurotoxicity of pre-incubated alpha-synuclein with neutral nanoliposomes on PC12 and SHSY5Y cell lines
905
Neurotoxicity of tissue plasminogen activator
906
Neurotoxicity studies on sucralose and its hydrolysis products with special reference to histopathologic and ultrastructural changes
907
Neurotoxicological manifestations among drug abusers admitted to Alexandria poison unit and Al-Mamora hospital: prospective study
908
Neurotoxin Botulinum Inserts Apoptotic Effects on Certain Cancer Cell Lines Via Neural Niche of Tumors: A Molecular Study
909
Neurotoxoplasmosios After Rituximab Therapy in Diffused Proliferative Glomerulonephritis Patient
910
NeuroTracker Three-Dimensional Multiple Object Tracking (3D-MOT): A Tool to Improve Concentration and Game Performance among Basketball Athletes
911
Neurotransmission and neuromodulation in the chemosensory carotid body
912
Neurotransmitter action in osteoblasts: expression of a functional system for serotonin receptor activation and reuptake
913
Neurotransmitter amino acid—oxobenzo[f]benzopyran conjugates: synthesis and photorelease studies
914
Neurotransmitter antagonism in management of irritable bowel syndrome
915
Neurotransmitter changes in the pathophysiology of Lesch–Nyhan syndrome
916
Neurotransmitter effect of galanin on the mean plasma concentrations of growth hormone, triiodothyronine, thyroxine, and milk protein in dairy goats sannan
917
Neurotransmitter interactions in schizophrenia—therapeutic implications
918
Neurotransmitter localization in the neuroepithelial cells and unipolar neurons of the respiratory tract in the bichir, Polypterus bichir bichir G. ST-HIL
919
Neurotransmitter receptor alterations in hepatic encephalopathy: A review
920
Neurotransmitters and Neuropeptides in the Developing Human Central Nervous System A Review
921
Neurotransmitters and signal transduction processes in bipolar affective disorders: a synopsis
922
Neurotransmitters and the Behavior of Individual Investors: Exploratory and Confirmatory Factor Analysis
923
Neurotransmitters and vulnerability of the developing brain
924
Neurotransmitters Disorders with Mild Hyperphenylalaninemia: The Ones That Should Not Be Missed
925
Neurotransplantation in Parkinsonʹs disease
926
Neurotrauma as an Evolving Indication for Neuromodulation
927
Neurotrauma Registries in Low- and Middle-Income Countries for Building Organized Neurotrauma Care: The LATINO Registry Experience; Comment on “Neurotrauma Surveillance in National Registries of Low- and Middle-Income Countries: A Scoping Review and Comparative Analysis of Data Dictionaries”
928
Neurotrauma Surveillance in National Registries of Low- and Middle-Income Countries: A Scoping Review and Comparative Analysis of Data Dictionaries
929
Neurotrimin and Syndecan-1 Biomarker Levels in Patients With Decompensated Heart Failure
930
Neurotrimin is an estrogen-inducible, uterine protein that mediates sympathetic axon repulsion
931
Neurotrophic activity of honokiol on the cultures of fetal rat cortical neurons
932
Neurotrophic and antileukemic daphnane diterpenoids from Synaptolepis kirkii Original Research Article
933
Neurotrophic corneal defect after diode laer cycloablation
934
Neurotrophic Corneal Ulcer after Topical Tetracaine Abuse: Management Guidelines
935
Neurotrophic Effects of Swimming and Crocin Consumption on the Rats with Obesity Induced by a High-fat Diet
936
Neurotrophic factor linked to Rettʹs syndrome
937
Neurotrophic factor linked to Rettʹs syndrome
938
Neurotrophic factors and regulation of mood: Role of exercise, diet and metabolism
939
Neurotrophic factors in relapsing remitting and secondary progressive multiple sclerosis patients during interferon beta therapy
940
Neurotrophic factors in the therapy of diabetic neuropathy
941
Neurotrophic peptide aldehydes: Solid phase synthesis of fellutamide B and a simplified analog
942
Neurotrophin expression in the reproductively senescent forebrain is refractory to estrogen stimulation
943
Neurotrophin receptor and tyrosine hydroxylase gene expression in aged sympathetic neurons
944
Neurotrophin regulation of development of vagal innervation of the gastrointestinal tract
945
Neurotrophin secretory pathways and synaptic plasticity Review Article
946
NEUROTROPHIN-3 (NT-3) PROMOTES REPARATIVE NEOVASCULARIZATION AND BLOOD FLOW RECOVERY IN A MOUSE MODEL OF LIMB ISCHEMIA
947
Neurotrophin-3 modifies potassium currents in isolated inner hair cells from guinea-pig cochlea
948
Neurotrophin-directed differentiation of human adult marrow stromal cells to dopaminergic-like neurons
949
Neurotrophins and Netrins Require Calcineurin/NFAT Signaling to Stimulate Outgrowth of Embryonic Axons
950
Neurotrophins and their receptors in early development of the mammalian nervous system
951
Neurotrophins and their receptors in the pigeon caecal tonsil: An immunohistochemical study
952
Neurotrophins and their receptors in the pigeon caecal tonsil: An immunohistochemical study
953
Neurotropin alleviates rat osteocarcinoma pain via P2X3 receptor activation in the midbrain periaqueductal gray
954
Neurotropism and neuropathological effects of selected rhabdoviruses on intranasally-infected newborn mice
955
Neurotuberculosis among Filipino children: an 11 years experience at the Philippine Childrenʹs Medical Center
956
Neurovascular bundle resection: Does it improve the margins?
957
Neuro-vascular central nervous recording/stimulating system: Using nanotechnology probes
958
Neurovascular compression syndrome with Meniereʹs disease—a report of the treatment of a patient with microvascular decompression
959
NEURO-VASCULAR CONFLICT AS CAUSATIVE FACTOR IN IDIOPATHIC TRIGEMINAL NEURALGIA
960
Neurovascular contact and blood pressure response in young, healthy, normotensive men
961
Neurovascular injury during removal of levonorgestrel implants
962
Neurovascular intervention
963
Neurovascular interventions
964
Neurovascular intervention-studies and strategies
965
Neurovegetative dystonia—Psychiatric evaluation of 40 patients diagnosed by general physicians in Brazil
966
Neurovegetative symptoms and complaints before and after voice therapy for nonorganic habitual dysphonia
967
Neurovegetative Symptoms in Multiple Sclerosis: Relationship to Depressed Mood, Fatigue, and Physical Disability
968
Neuroviual rehabilitation: recent development and future direction
969
Neurulation in the cranial region - normal and abnormal
970
Neustonic microplastic and zooplankton in the North Western Mediterranean Sea
971
NEUTIT: a computer program for evaluating equivalence volumes and ionization constants in polar non-aqueous or partially aqueous media
972
Neutra and Kreutzer Reply to "Invited Commentary: Sensitivities to Chemicals Context and Implications" by Kipen and Fiedler
973
Neutra and Kreutzer Reply to "Invited Commentary: Sensitivities to Chemicals Context and Implications" by Kipen and Fiedler
974
Neutral (beta)-diketiminato nickel(II) monoalkyl complexes
975
Neutral 5-substituted 4-anilinoquinazolines as potent, orally active inhibitors of erbB2 receptor tyrosine kinase
976
Neutral 5-substituted 4-indazolylaminoquinazolines as potent, orally active inhibitors of erbB2 receptor tyrosine kinase
977
Neutral acetohydroxamic acid coordination to a mononuclear Ni(II) center stabilized by an intramolecular hydrogen-bonding interaction
978
Neutral additives enhance the metal-chelate affinity adsorption of nucleic acids: Role of water activity
979
Neutral adsorptive capture of particles by membranes: network modeling near the membrane isoelectric point
980
Neutral aldoses as source indicators for marine snow
981
Neutral aluminum and gallium four particle complexes in silicon carbide polytypes
982
Neutral aluminum and gallium four particle complexes in silicon carbide polytypes
983
Neutral amino acids monitoring in phenylketonuric plasma microdialysates using micellar electrokinetic chromatography and laser-induced fluorescence detection
984
Neutral analyte focusing by micelle collapse in micellar electrokinetic chromatography
985
Neutral and anionic CuO2: an ab inito study
986
Neutral and cationic (η6-arene)-ruthenium(II) complexes containing the iminophosphorane–phosphine ligand Ph2PCH2P(N-p-C5F4N)Ph2: influence of the arene ring in catalytic transfer hydrogenation of cyclohexanone
987
Neutral and cationic cyclometallated Ir(III) complexes of anthra[1,2-d]imidazole-6,11-dione-derived ligands: Syntheses, structures and spectroscopic characterisation
988
Neutral and cationic Fe(II) β-diketiminate complexes
989
Neutral and cationic multinuclear half-sandwich rhodium and iridium complexes coordinated to poly(propyleneimine) dendritic scaffolds: Synthesis and cytotoxicity
990
Neutral and cationic osmium(II)-arene metallodendrimers: Synthesis, characterisation and anticancer activity
991
Neutral and cationic palladium(II) and platinum(II) complexes of 2,2′-dipyridylamine with saccharinate: Syntheses, spectroscopic, structural, fluorescent and thermal studies
992
Neutral and cationic rare-earth metal alkyl complexes that contain bis(2-methoxyethyl)(trimethylsilyl)amine, a neutral [ONO]-type ligand
993
Neutral and cationic trimethylsilylmethyl complexes of the rare earth metals supported by a crown ether: synthesis and structural characterization
994
Neutral and charged current cross sections at high Q2 at HERA Original Research Article
995
Neutral and charged donor in a 3D quantum dot
996
Neutral and charged excitons in a quantum tube
997
Neutral and charged magnetic excitons in finite-width quantum rings
998
Neutral and charged polymers at interfaces
999
Neutral and charged polymers at interfaces
1000
Neutral and dianionic iron and ruthenium 1,4-diphosphabutadiene complexes